BACKGROUND
Mainzer-Saldino syndrome (MSS, MIM# 26692) is a rare (<1 out of 1,000,000) autosomal recessive ciliopathy characterized by severe early-onset retinal dystrophy, phalangeal cone-shaped epiphyses, chronic renal failure, and mild radiographic abnormality of the proximal femur (Perrault et al., 2012) , known to be caused by IFT140 (Khan, Bolz, & Bergmann, 2014; Perrault et al., 2012; Schmidts et al., 2013) and IFT172 mutations (Halbritter et al., 2013) . Both genes have been implicated in several other ciliopathies ranging from isolated retinis pigmentosa (RP) to more syndromic cases such as Jeune (JATD; MIM# 208500) or Bardet-Biedl syndromes (BBS; MIM# 209900) (Bifari, Elkhamary, Bolz, & Khan, 2016; Bujakowska et al., 2015; Schaefer et al., 2016) . . Table S1 ), encompassing missenses, essential splice sites, stop and frameshifts mutations but no structural variations (SV) such as copy number variant (CNV). Interestingly, 10 mono allelic variants cases have also been reported with no second pathogenic allele detected to date (Supp . Table S1 ).
In this study, we report for the first time a SV (tandem duplication) in IFT140 identified by whole-genome sequencing (WGS) and missed by whole-exome sequencing (WES). The impact of this mutation was further assessed in patients' skin fibroblasts. Given the difficulty to identify this mutation and the genomic context surrounding the breakpoints, we speculated that it might have been missed by other genetic screenings and that several other families might carry this mutation.
We finally report eight unrelated families carrying the mutation either at the homozygous or the heterozygous state, out of 11 families identified with IFT140 biallelic mutations in total. Moreover, the characterization of the breakpoints allowed to delineate a potential molecular mechanism and to design a specific duplex PCR that will help screening further patients (including our cohorts).
MATERIALS AND METHODS

Subjects
Study protocols used in each cohort have been approved by the corresponding Institutional Review Board or equivalent committees (as an example in Strasbourg, "Comité Protection des Personnes" EST IV, N • DC-20142222), and written informed consent was given from each participant or parents. Our research complies with the Declaration of Helsinki. Written informed consent for open-access publication was provided by the participants or their parents. DNA of additional affected and unaffected family members was requested whenever it was considered informative. Skin fibroblasts were obtained for family A. Clinical data for all 11 families are presented in Supp. Table S2 .
Whole-genome sequencing
WGS was performed for the two affected siblings from family A (A-II.1 and A-II.2) and their parents (A-I.1 and A-I.2) by the Centre National de Génotypage (Institut de Génomique, CEA). Genomic DNA was used to prepare a library for WGS, using the Illumina TruSeq DNA PCRFree Library Preparation Kit, according to the manufacturer's instructions. After normalization and quality control, qualified libraries have been sequenced on a HiSeq2000 platform from Illumina (Illumina, San Diego, CA, USA), as paired-end 100 bp reads. At least three lanes of HiSeq2000 flow cell have been produced for each sample, in order to reach an average sequencing depth of 30× for each sample. Sequence quality parameters have been assessed throughout the sequencing run and standard bioinformatics analysis of sequencing data was based on the Illumina pipeline to generate FASTQ file for each sample. The sequence reads were aligned to the reference sequence of the human genome (GRCh37) using the Burrows-Wheeler Aligner (BWA V7.12) (Li & Durbin, 2010) . The UnifiedGenotyper and HaplotypeCaller modules of the Genome Analysis ToolKit (GATK) (DePristo et al., 2011) , Platypus (https://www.well.ox.ac.uk/platypus), and Samtools (Li et al., 2009 ) were used for calling both single nucleotide variations (SNV) and small insertion/deletion (indel).
Bioinformatics analysis
Annotation and ranking of SNV and indel were performed by VaRank (Geoffroy et al., 2015) in combination with the Alamut Batch software (Interactive Biosoftware, Rouen, France). Very stringent filtering criteria were used for excluding nonpathogenic variants, in particular:
(1) variants represented with an allele frequency of more than 1% in public variation databases either dbSNP 138 (Sherry et al., 2001) , the Exome Variant Server (NHLBI GO Exome Sequencing Project, https://evs.gs.washington.edu/EVS/), the 1000Genomes (Genomes Project et al., 2015) , the ExAC browser database (Lek et al., 2016) or our internal exome database, (2) (Shapiro & Senapathy, 1987) . Our analysis was focused on compound heterozygous and homozygous variants (SNV/indel/SV) consistent with a recessive mode of transmission. Structural variants were predicted using by default the CANOES program (Backenroth et al., 2014) and annotated thanks to our in house script AnnotSV (Geoffroy et al., 2018) based on the classical annotations such as the Database of Genomic Variants (DGV) (MacDonald, Ziman, Yuen, Feuk, & Scherer, 2014) . The IFT140 nomenclature is based on the accession number NM_014714.3 from the RefSeq database (O'Leary et al., 2016) .
Genomic coordinates are defined according to GRCh37/hg19 assembly downloaded from the University of California Santa Cruz (UCSC) genome browser (Tyner et al., 2017) .
Sanger validation and segregation
Sanger sequencing was performed by PCR amplification with 50 ng of genomic DNA template. The primers were designed with Primer 3 (https://frodo.wi.mit.edu/primer3) and are detailed in Supp. Table S3 .
Bidirectional sequencing of the purified PCR products was performed by GATC Sequencing Facilities (Konstanz, Germany).
qPCR quantification
Absolute quantification was performed using the SyberGreen Master- 
RNA analysis
RNA was extracted from skin fibroblasts of individual II.1 and a healthy unrelated control using Rneasy RNA kit (Qiagen) then we performed reverse transcription using the iScriptTM cDNA Synthesis Kit (BioRad, Hercules, CA).
Cell culture
Fibroblasts of patients and control individuals were obtained by skin biopsy as previously described (Scheidecker et al., 2014) . To induce primary cilium formation, cells were deprived of serum by growth for 24 hr in DMEM with 1% PSG but only 0.1% FCS (conditions-FCS) as previously described .
Immunofluorescence
Primary fibroblasts from patients and control individuals were grown in Nunc Lab-Tek chamber slides (Thermo Scientific, Waltham, MA, USA) and ciliogenesis was done as described in the cell culture section.
Primary cilia were labeled with an antibody directed against acetylated a-tubulin highlighting the axoneme. Pictures were taken either on a fluorescence microscope ( Figure 2A ) or a confocal microscope (Figure 2C) . Primary and secondary antibodies used in this study as well as their dilution are indicated in Supp. Table S4 .
Cohort screening
A duplex PCR was designed to specifically detect the tandem duplication. Primers and example conditions are provided in Supp. Table S3 and Supp. Figure S1 . Additional targeted exome sequencing datasets have been reanalyzed (see Supp. Materials and Methods).
Alu pair analysis
We obtained the annotations and sequences for the two Alu repeat in the duplication junction region from the RepeatMasker track of the UCSC genome browser (Tyner et al., 2017) . We subsequently aligned the Alu sequences and computed the identity using the online tool EMBOSS Matcher (Rice, Longden, & Bleasby, 2000) .
RESULTS
Identification of biallelic mutations in IFT140
Two affected individuals born from healthy nonconsanguineous parents (family A, Figure 1A ), named II.1 and II.2, were referred to our lab with retinitis pigmentosa, short stature (152 and 158 cm respectively at 16 and 15 yo), brachydactyly, moderate renal failure and overweight for II.1 (Supp . Table S2 ). This Bardet-Biedl like phenotype prompted us to perform an extensive first genetic analysis including Sanger sequencing of recurrent BBS mutations (Muller et al., 2010) , targeted exome sequencing (Redin et al., 2012) , and WES without success. Indeed no biallelic mutations including CNV could be identified (see Supp. Table S5 Sanger sequencing was performed on RNA extracted from fibroblasts of individual II.1 and a healthy unrelated control amplified between exon 18 and exon 22. C: M2 analysis. Quantitative real-time PCR was performed on DNA from exon 30 in all individuals from family A and one unrelated control. DNA quantity from exon 30 of IFT140 was compared with two reference genes (HBB and HMBS) using the absolute quantification method. Ratios can be interpreted as following: homozygous deletion (ratio < 0.1), heterozygous deletion (0.3-0.7), normal situation (0.8-1.2), duplication (1.3-1.6), and triplication (>0.8). Error bars represents standard deviation. D: M2 RNA expression in patient's II.1 skin fibroblasts is demonstrated by PCR amplification (PRMT9 as a control) and by Sanger sequencing. The cDNA sequence revealed that the normal exon 30 is followed by again exon 27 and exon 28. E: IFT140 expression in skin fibroblasts was revealed by western blot using anti-IFT140 antibody. GAPDH and -Tubulin were used as loading controls predicted to add seven new amino acids to the protein sequence (p.Leu859_Glu860insValArgGlyAlaArgHisGly) ( Figure 1B ). Second, in trans to this mutation, structural variant analysis revealed a maternally inherited ( Figure 1A ) duplication of exons 27-30 (of sizes 6.7 kb). Analysis of the mapped reads revealed that the duplication is occurring in tandem in direct orientation within the gene (Supp. Figure S2 ) with breakpoints located in intron 26 and intron 30. This tandem duplication has not been reported previously in patients and is not present in DGV. The results were confirmed by qPCR ( Figure 1C ) delineating the expected maternal inheritance.
The duplication is predicted to be in frame and to add 243 amino acids within the tetratricopeptide repeat (TPR) domain of the IFT140 protein (c.3454-488_4182+2588dup, p.Tyr1152_Thr1394dup). RNA analysis revealed that the duplicated exons are transcribed (Figure 1D) . Western blot analysis revealed only a single band of the approximate size of the wild-type protein suggesting that the allele carrying the duplication is not detected as a protein ( Figure 1E ).
Immunofluorescence analysis in patients fibroblasts revealed that these cells develop less primary cilia and that IFT140 is mislocalized compared to sex/age matched control cells. Indeed, when grown in ciliary conditions, patient skin fibroblasts developed primary cilia less often ( Figure 2A ). Thus while 75% of control cells developed a primary cilium, only about 50%-55% of patient cells did so ( Figure 2B ). It is to notice that primary cilia did not seem to be altered since when cells Figure 2C ). Then, localization of IFT140 at the base of the cilium could be observed using confocal microscopy in 82% of ciliated control cells but only in about 14% of ciliated patient fibroblasts ( Figure 2D) . Thus, the mutations found in the patients lead to a significant decrease of cilium formation and a loss of IFT140 localization at the base of the cilium.
Mutation screening in a large cohort
To explore additional cases of this duplication possibly missed by prior analysis, we retrospectively screened our cohorts and reanalyzed available high throughput sequencing panels including the Figure S1) and screened all our negative cases, including 207 from our BardetBiedl cohort, 150 isolated RP and 40 IFT140 heterozygous patients.
Altogether, we identified 11 additional families positive for biallelic mutations in IFT140 (Figure 3 and Supp. Table S1 ) among which 10 families have a phenotype compatible with a MSS and one patient presents with isolated retinitis pigmentosa. Among the MSS patients, three patients presented a phenotype overlapping with another ciliopathy: two with Jeune syndrome and one with Sensenbrenner syndrome.
Eight of the 11 families carried the exact same tandem duplication either at the heterozygous state (three copies) or at the homozygous state (four copies) ( Figure 3A and Supp. Figure S3 ). Among the novel mutations identified, we observed two missenses at the heterozygous state c.1319T > C (p.Leu440Pro), c.2177C > T (p.Pro726Leu) that are both predicted deleterious (Supp. Materials and Methods). Among the novel mutations we also identified another CNV, a large deletion encompassing exon 27-29 (c.3454-1005_4040+737delinsCCC; Supp. Figure S4 ) that does not share the same breakpoints compared with the tandem duplication. Thus to date, 120 pathogenic alleles have been reported for IFT140 of which the tandem duplication represents 10 alleles. Interestingly this tandem duplication is the second most frequent mutation for IFT140-affected patients.
Founder effect or recurrent mechanism?
Given the relatively high frequency (eight out of 65 families) of this duplication in the patients described with IFT140 mutations, we performed three additional explorations to assess whether the duplication was an independent recurrent mechanism or the same muta- as expected due to the IFT140 diseases prevalence (e.g., MSS: one out of 1,000,000). Second, we compared the haplotype at the IFT140 locus from the different patients for which NGS data was available. In total 15 haplotypes, including six carrying the duplication, from three different families, were analyzed (see Supp. Table S6 ). We observed a shared haplotype between the duplication carriers at the IFT140 locus, suggesting a founder effect. Third, we characterized the genomic localization around the breakpoint junctions. Sanger sequencing confirmed the breakpoint's coordinates ( Figure 1A and Supp. Figure S2) and demonstrated that the exact same breakpoint is shared among all patients tested (Family C was not investigated). The breakpoints overlapped two distinct repeated elements from the Alu family, AluJb and AluJr ( Figure 4A ). Pairwise alignment of the two Alu sequences (Supp. Figure S5 ) revealed a conservation of 68% of identity that reached 81% in the junction region ( Figure 4B ). The tandem duplication is resulting in an Alu hybrid ( Figure 4C ) at both sides. Alu-Alu recombination is a prominent mechanism underlying the formation of pathogenic SV (Boone et al., 2014; Stankiewicz et al., 2009 ). Altogether, this led us to speculate that this tandem duplication is a rare event, which arises from a common ancestor due to an Alu-Alumediated genomic recombination.
DISCUSSION
The advent of next-generation sequencing (NGS), especially WES, in the past 10 years was a tremendous step that led to the identification of many mutations accelerating the discovery of novel genes involved in human genetic diseases (Chong et al., 2015) . Nevertheless, the diagnostic yield of WES is plateauing between 25% and 50% depending on the disease (Chong et al., 2015; Taylor et al., 2015) leaving many patients still with no molecular diagnosis. The use of RNA sequencing has recently extended the percentage by 10%-66% (depending on the context: with or without a strong candidate by prior DNA sequencing) by helping identifying unseen defects or interpreting variations found in the WES (Cummings et al., 2017; Kremer, et al., 2017) . Lastly, WGS of human patients has proven to be an instrumental tool for identifying the whole spectrum of genetic anomalies (Gilissen et al., 2014) and will replace in a close future other genetic screening.
In line with this, we applied a range of genetic screening including targeted sequencing, WES and then finally WGS to unsolved patients affected with a ciliopathy. The combination of WGS and CNV analysis was able to uncover a tandem duplication unseen by the WES and to reconsider a distant splice site mutation.
Interestingly, the tandem duplication could be identified in family A only by using the WGS and not the WES data. Indeed, CANOES failed to identify the event in one of the individuals (Supp . Table S7 ), which prevented us from considering this as a mutation of interest but made us rather discard it as a false positive of the method. Thereupon, it is well known that CNV detection from NGS datasets is feasible and many publication reported positive results either on gene panels or WES (de Ligt et al., 2013; Redin et al., 2012) . However, this remains challenging (Tan et al., 2014) . WGS provides a much more uniform distribution of sequencing-quality parameters and by nature does not have the restriction of noncontiguous regions of interests (captured exons). Therefore, it is more suited for SV identification (Belkadi et al., 2015) . Having that in mind, we further tested the CNV detection using two other popular programs (see Supp. Table S7 ) that failed to detect the tandem duplication in family A patients (Supp . Table S7 ).
These results confirmed many efforts are still required to ensure a high-quality CNV detection from NGS data, even with the large number of programs and methods available. Nevertheless, thanks to the split reads from WGS data, once a CNV is detected one can easily define the CNV breakpoints and further characterize the mechanism, as done in this study (Supp. Figure S2) .
Analysis of the breakpoint positions and in particular the split reads allowed us to identify overlapping Alu elements at the breakpoint junction. Alignment of the Alu regions surrounding the junction revealed that both elements share 81% identity and exhibit a microhomology region of six nucleotides. Because the recombination occurred between homologous sequences (e.g., imperfect match substrates), it is most likely mediated by mechanisms other than nonallelic homologous recombination, which are mostly recurrent events (NAHR, for review see (Carvalho & Lupski, 2016) ). Among the possible molecular mechanisms, that include nonhomologous end joining (NHEJ) and Table S1 ). The most frequent mutation (31 alleles) is a missense (c.1990G > A, p.Glu664Lys) that has been observed in multiple studies and especially in 11 consanguineous families from the Arabian Peninsula sharing a common ancestor (Bifari, Elkhamary, Bolz, & Khan, 2016) which might bias the allele count. Nevertheless, the tandem duplication described in our study is the second most frequent cause of mutation in IFT140 representing 10 alleles.
In family A, the two mutations identified required extensive and careful analysis to be considered. One mutation was predicted to affect the splicing of exon 20 (c.2577+25G > A) which was confirmed at the RNA level (r.2577_2578insGTGAGGGGCGCCCGCCATGGG), and suggested to add 7 amino acid to the protein sequence (p.Leu859_ The MSS is a syndrome characterized by skeletal phenotype with phalangeal cone-shaped epiphyses, chronic renal disease, and retinal dystrophy. Overlapping phenotypes have been described with other skeletal ciliopathies such as the Jeune or Sensenbrenner syndrome. In our cohort, the diagnosis of MSS was not made in all patients before the molecular analysis. However, all of them except one with an isolated retinitis pigmentosa, fulfilled the criteria for this diagnosis after a new careful clinical and radiological examination. Indeed, 11 patients presented digits anomalies, including eight with phalangeal cone-shaped epiphyses. Nine patients developed renal failure among which seven have a severe and early onset renal disease (1.5 years old to 23 years old) as previously described . The retinal dystrophy is constantly reported with a highly variable age of onset. Among our cohort, a single patient presented an isolated retinitis pigmentosa (as previously reported by others (Hull et al., 2016) ). Two patients have thoracic dystrophy which is a clinical criteria of Jeune syndrome and one patient has a craniosynostosis compatible with a Sensenbrenner syndrome. These descriptions illustrate well the overlap existing between the different ciliopathies associated with mutation in IFT140.
On a molecular level, no genotype-phenotype correlation could be established in our cohort, especially regarding the patients carrying the duplication at the homozygous or the heterozygous state.
CONCLUSIONS
We report here 11 novel unrelated families with mutations in IFT140.
Among them, eight families carry a recurrent tandem duplication of four exons either at the heterozygous state or the homozygous state, for which we have assessed the pathogenicity in the patients cells. This is the first time that a SV is reported in IFT140 expanding the mutation spectrum for this gene. Notably, this large duplication was missed by the WES analysis but uncovered thanks to the whole genome, pointing out the power of such analysis.
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